# Specialist Agent Record Draft

## A. Agent and Version

- Repository / branch / commit: `kh4214/MASY1800-ET-Agent-Lab` / `promethean-classification-agent` / **REVIEW AFTER COMMIT**
- Agent / assignment: Promethean Technology Classification Agent / Lab 4
- Version: 0.2-student
- Purpose: Apply Chapter 11 categorical-barrier and cross-tier transformation logic without changing the frozen common contracts.

## B. Specialist Purpose and Context

The agent distinguishes Incremental, Breakthrough, Potentially Promethean, and Insufficient Evidence. It requires a defensible categorical barrier, a reduction-versus-dissolution finding, separate demonstrated and plausible cross-tier effects, six supporting criteria, strongest evidence for and against, and a bounded management implication.

## C. Three-Level Finding

- General ET finding: Implantable BCI systems for communication and digital-device control are a **Breakthrough** with moderate confidence. Selected investigational participants demonstrate meaningful bypass of impaired output channels, but broad durable categorical-barrier dissolution across two tiers is not established.
- Application finding: For severe paralysis, communication and computer access directly address the relevant constraint. Results are promising clinical-research evidence, not proof of routine clinical efficacy or human enhancement.
- Organization-specific finding: The large teaching hospital may consider a limited, governed research role; the smaller risk-averse hospital should use referral/monitoring rather than initiate a program. The classification does not change.

## D. Evidence and Testing

- Primary record: `responses/primary_response.json`; contrast record: `responses/contrast_1_response.json`.
- Evidence for: FDA implanted-BCI guidance; Willett et al. (Nature, 2023); NIH summary of 2025 speech work; Willett et al. (Nature, 2026). Full traceable references are embedded in the response records.
- Strongest contrary evidence: very small specialized studies, invasiveness, uncertain durability/generalizability, constrained access, and absent demonstrated broad cross-tier transformation.
- Stable contrast conclusion: technology classification, evidence base, and absence of proven widespread cross-tier impact.
- Changed contrast conclusion: the large hospital could explore a bounded study; the smaller hospital lacks stated infrastructure and should not initiate within three years.
- Preserved failure: `primary_v0_1_schema_failure.json` contains a specialist-only top-level `promethean_criteria` object. It violates the frozen schema's `additionalProperties: false` contract. The bundled validator checks required fields/types but does not enforce that rule, so the incompatibility was identified by direct comparison with `core/output_schema.json` rather than by claiming a bundled-validator failure.
- Revision: version 0.2 maps criteria, tests, evidence for/against, and management boundaries into existing common fields. The revised primary and contrast records pass the bundled validator and have no top-level fields outside the frozen schema.
- Reproducibility issue fixed: the first prompt-packet build failed because the frozen Python tool uses the Windows default encoding and could not read typographic quotation marks/en dashes in the editable instructions. The instructions were converted to ASCII punctuation only; both packets then built successfully. The frozen tool was not changed.
- Remaining limitation: no interactive ChatGPT execution was available in this development session. Schema validation verifies structure only; it does not independently validate the content, sources, or model behavior.

## E. Independent Judgment and Handoff

**REQUIRES STUDENT REVIEW:** See `independent_professional_judgment.md` before submitting. The next team should preserve the fixed schema, three-level separation, and explicit uncertainty about future effects; see `team_handoff.md`.

## AI and Verification Note

Codex helped inspect the scaffold, create the editable package, build packets, and validate JSON. Consequential BCI claims were tied to FDA, NIH, PubMed, and primary-study references. The student must independently review source fit and the professional judgment before submission. No claim is based solely on model memory.
